The short version of Lyophilization fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-01-19 and is reviewed periodically as new material appears.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
| Property | Value | Notes |
|---|---|---|
| Storage temperature (dry) | -20 °C | Protected from light and moisture |
| Storage temperature (solution) | -80 °C | Single-use aliquots recommended |
| Identity assay | LC-MS or MALDI-TOF | Confirms mass near 889 Da |
| Purity assay | RP-HPLC | Reports main peak percentage |
| Common impurities | Truncated peptides, deamidated forms | Arise from synthesis or storage |
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
=== Synthesis === Hydrocodone is most commonly synthesized from thebaine, a constituent of opium latex from the dried poppy plant. Once thebaine is obtained, the reaction undergoes hydrogenation using a palladium catalyst.
=== Automated fast-flow synthesis of biopolymers === The Pentelute laboratory designs fully automated fast-flow machines to accelerate the chemical manufacture of sequence-defined biopolymers. It has built an efficient machine that can produce amide bonds an order of magnitude faster than commercially available instruments. The machine is inspired by Nature's ribosome that can make proteins in minutes. While the Pentelute group's fast-flow technology is not as fast as the ribosome, it can form one amide bond in 7 seconds. This technology not only facilitates rapid polypeptide generation but it has enabled the group to carry out entire D-scans of proteins to investigate folding and functions. This technology was used to achieve stepwise total chemical synthesis of functional protein chains and was adapted to produce phosphorodiamidate morpholino oligomers (PMO) in flow. Automated flow technology may be used to solve the manufacturing problem for on-demand personalized therapies, such as cancer vaccines, and to design engineered biologics, such as dimeric transcription factor mimetics.
Congenital hereditary endothelial dystrophy (CHED): There are 2 forms of congenital hereditary endothelial dystrophy (CHED). Commonest is an autosomal recessive form, which is present at birth, but nonprogressive. Nystagmus is seen in association with this form. Another is an autosomal dominant form that occurs within the first few years of life. This form is progressive, but nystagmus is not seen. Deafness and CHED are seen in Harboyan syndrome. The histologic findings are very similar to those seen in pseudophakic/ aphakic bullous keratopathy. The appearance of the cornea is similar to that in congenital glaucoma but without increased corneal diameter and elevated intraocular pressure. Posterior polymorphous corneal dystrophy (PPMD, PPCD): PPCD, also known as Schlichting dystrophy, is an autosomal dominant disorder of the corneal endothelium and Descemet's membrane. It is usually present in the second or third decade of life. It has the same entity as the first form of CHED. Most cases of PPMD are asymptomatic, and these cases generally do not require treatment. PPMD patients with bilateral, corneal opacities that can affect vision, descemet's membrane endothelial keratoplasty or penetrating keratoplasty are the treatments of choice to improve vision and to avoid amblyopia. Congenital hereditary stromal dystrophy (CHSD): CHSD is also known as Congenital stromal corneal dystrophy or Congenital stromal dystrophy of the cornea. It is a rare autosomal dominant disease caused by mutations in the DCN gene.
== History == HFAP was established in 1943 by the American Osteopathic Association (AOA), and began surveying hospitals in 1945. Initially, HFAP provided osteopathic hospitals with accreditation ensuring osteopathic residents received appropriate training. In the mid-1960s the United States Congress decided that accredited hospitals would meet conditions set for participation, and thus automatically participated in newly established Medicare and Medicaid programs. HFAP quickly applied for and was granted said status in 1965. By 2012, HFAP accredited about 214 hospitals in the US. In 2015, ownership of HFAP moved from the AOA to the Accreditation Association for Hospitals/Health Systems (AAHHS).
==== Minor Alienizers ==== Lovelian Balance (ラブーリ星人バラン・スー, Rabūri Seijin Baran Sū): A giant non-humanoid alien from Planet Lovely who smuggled the Fan Crusher's control mechanism for Don Moyaida, who subsequently betrayed him. In a fit of rage, Balance takes a bus and its occupants hostage, but is easily defeated and arrested by Deka Blue, Green, Yellow, and Pink. Diamantian Don Moyaida (ディアマンテ星人ドン・モヤイダ, Diamante Seijin Don Moyaida): A diamond-themed criminal from Planet Diamante who is charged with infanticide, vehicular manslaughter, and the theft of terrestrial resources. He was originally believed to have died following a car chase with Ban in his combat vehicle-themed Kaijuki, Scarabader (スカラベーダー, Sukarabēdā), but Don Moyaida resurfaces on Earth disguised as a human to use his primary drill vehicle–like Kaijuki, Fan Crusher (ファンクラッシャー, Fan Kurasshā), to harvest the planet's resources and produce space jewelry as well as give Agent Abrella information on the Deka Base's Anubisium, the material used in its walls' construction. Don Moyaida succeeds in the latter task before he is deleted by Deka Red, while the Fan Crusher is destroyed by Dekaranger Robo. Don Moyaida is voiced by Takanori Kikuchi (菊池 隆則, Kikuchi Takanori), who also portrays his human form. Grorserian Hell Heaven (グローザ星人ヘルヘヴン, Gurōza Seijin Heru Hevun): A criminal and underling of Kevakia from Planet Grorser who is charged with kidnapping for profit-making and murder in Star-29.
Sources: en.wikipedia.org
=== Partnerships === In 2017, the company announced partnerships with major pharmaceutical companies to negotiate lowering prescription drug costs. GoodRx has deep relationships with major pharmacy chains, including Walgreens, Walmart, CVS Caremark, and Publix, to allow customers to use GoodRx discounts and Gold benefits. GoodRx began its partnership with CVS Caremark in July 2023 to automatically apply coupons to insured CVS customers purchasing generic prescriptions at certain locations. In April 2024, GoodRx added Publix into its network, allowing GoodRx Gold members to use their cards at Publix Pharmacies. GoodRx partners with Pharmacy Benefit Management like Caremark, Express Scripts, and MedImpact to apply their savings directly to eligible insurance plans and members. GoodRx partners with companies like Affirm, Benefitfocus, and DoorDash to integrate their services that offer members discounts and financial flexibility for prescriptions. GoodRx also partners with organizations like the American Academy of Family Physicians Foundation to support broader access to care. In October 2022, GoodRx launched Provider Mode, which allows healthcare providers to use the app to compare costs of drugs for patients based on different payment methods and drug alternatives. In 2025, GoodRx partnered with Novo Nordisk to offer discounted cash-pay access to semaglutide products like Ozempic and Wegovy through its platform and participating pharmacies.
== Reactivity == One of the cytochrome P450 isozymes is coded by the gene CYP2B1, where hexobarbital is the substrate. Hexobarbital and the isozyme can form an enzyme-substrate-complex through a hydroxylation reaction, which is involved in the metabolism of xenobiotics. the concentration of hexobarbital also plays a role in oxygenase and oxidase activity of hepatic microsomal cytochrome P450. Triacetyl oleandomycin, an inhibitor for isozyme CYP3A4, also inhibits hexobarbital metabolism and biological activity, indicating a close relationship between hexobarbital and cytochrome P450.
==== Investigation of Bruno Pacheco ==== On 16 November 2021, leaked chats showed that then presidential secretary Bruno Pacheco attempted to pressure the SUNAT to favor certain companies and individuals. On 19 November 2021, Bruno Pacheco resigned as presidential secretary due to his role in the Walter Ayala controversy, regarding attempts to irregularly promote military personnel. Pacheco maintained that he was resigning in order to stop the smear campaign against the President. His position was replaced by Carlos Jaico. On 23 November 2021, the Public Prosecutor's Office found $20,000 in cash inside Pacheco's office bathroom in the Governmental Palace. Pacheco claimed that this money came from his savings and the salary he received. On 24 November 2021, Alejandro Aguinaga, a Popular Force parliamentarian and president of the Congressional Oversight Commission called on Prime Minister Mirtha Vásquez to indicate what measures would be taken against Pacheco. In response, the Free Peru parliamentarian Guillermo Bermejo accused the Fujimorist Popular Force of double standards and brought up corruption charges against Alberto Fujimori and Vladimiro Montesinos. Meanwhile, the former prime minister Guido Bellido said "It makes me suspicious that someone goes to work with his 20 thousand dollars," and stated that it would be evaluated and taken into account in Free Peru's stance on the impeachment motion.
RNA editing (also RNA modification) is a molecular process through which some cells can make discrete changes to specific nucleotide sequences within an RNA molecule after it has been generated by RNA polymerase. It occurs in all living organisms and is one of the most evolutionarily conserved properties of RNAs. RNA editing may include the insertion, deletion, and base substitution of nucleotides within the RNA molecule. RNA editing is relatively rare, with common forms of RNA processing (e.g. splicing, 5'-capping, and 3'-polyadenylation) not usually considered as editing. It can affect the activity, localization as well as stability of RNAs, and has been linked with human diseases. RNA editing has been observed in some tRNA, rRNA, mRNA, or miRNA molecules of eukaryotes and their viruses, archaea, and prokaryotes. RNA editing occurs in the cell nucleus, as well as within mitochondria and plastids. In vertebrates, editing is rare and usually consists of a small number of changes to the sequence of the affected molecules. In other organisms, such as squids, extensive editing (pan-editing) can occur; in some cases the majority of nucleotides in an mRNA sequence may result from editing. More than 160 types of RNA modifications have been described so far. The discovery of RNA modifications that result in the suppressing of immunogenicity of therapeutic mRNA led to their eventual adoption for COVID mRNA vaccines, and was recognized with the 2023 Nobel Prize in Physiology or Medicine to Katalin Karikó and Drew Weissman.
== Interactions == Carbamazepine and other enzyme inducers may reduce plasma levels of risperidone. If a person is taking both carbamazepine and risperidone, the dose of risperidone will likely need to be increased. The new dose should not be more than twice the patient's original dose. CYP2D6 inhibitors, such as the SSRI medications fluoxetine and paroxetine, may increase plasma levels of risperidone. Since risperidone can cause hypotension, its use should be monitored closely when a patient is also taking antihypertensive medicines to avoid severe low blood pressure. Risperidone and its metabolite paliperidone are reduced in efficacy by P-glycoprotein inducers such as St John's wort. Risperidone has been found to dose-dependently block the effects of serotonergic psychedelics like psilocybin and lysergic acid diethylamide (LSD).
Sources: en.wikipedia.org
22 December A network model analysis suggests that temporary overshoots of climate change – increasing global temperature beyond Paris Agreement goals temporarily as often projected – can increase risks of climate tipping cascades "by up to 72%". In a paywalled article, scientists provide 3D imaging and model analysis to reveal main causes, mechanics, and potential mitigations of the problematic prevalent lithium-ion battery degradation over charge cycles. 26 December – Bio- and electrical engineers prove for the first time that human cerebral organoids transplanted into mice (see 17 Aug 21 and 12 Oct) functionally integrate with their visual cortex. 27 December – Scientists report that a species of Halteria, a single-celled protozoan, is the first known organism for which "a virus-only diet ... is enough to fuel the physiological growth and even population growth".
== Molecular weight distribution in linear polymerization == The product of a polymerization is a mixture of polymer molecules of different molecular weights. For theoretical and practical reasons, it is of interest to discuss the distribution of molecular weights in a polymerization. The molecular weight distribution (MWD) had been derived by Flory by a statistical approach based on the concept of equal reactivity of functional groups.
A number of security incidents are reported in London, Gatwick Airport and Chester, involving evacuations and anti-terror police. Queen Camilla misses the Royal Variety Performance because of "lingering post-viral" symptoms from her chest infection. 23 November The Ministry of Justice says it is aware of a data breach after details of the layouts of prisons in England and Wales were leaked to the dark web. Kensington Palace announces that the Princess of Wales has invited the families affected by the 2024 Southport stabbing to her annual Christmas carol service. It is reported that Andy Murray will coach his long-time former rival Novak Djokovic at the 2025 Australian Open. Less than five months after Labour won the 2024 general election, an online parliament petition calling for a new general election is launched and receives 200,000 signatures within its first six hours. 23–24 November – A number of yellow weather warnings for high winds and heavy rain are in place for Scotland, Northern Ireland, north Wales and northern England as Storm Bert arrives in the UK; there is also an amber alert for snow and ice in central Scotland. 24 November BBC News reports that businessman David Crisp, who was recorded telling an undercover reporter he was illegally selling luxury perfume to Russia, will not face criminal charges. An eight-year-old girl and a 34-year-old man are seriously injured in a shooting in Ladbroke Grove, West London. A 22-year-old man is arrested the following day on suspicion of attempted murder.
== External links == Anatomy figure: 04:04-07 at Human Anatomy Online, SUNY Downstate Medical Center – "Muscles of the anterior chest wall with the pectoralis major muscles removed." "Anatomy photo:18:01-0115". SUNY Downstate Medical Center. Archived from the original on March 5, 2016. – "Thoracic Wall: The Anterior Thoracic Wall" Anatomy figure: 35:06-07 at Human Anatomy Online, SUNY Downstate Medical Center – "Incision and reflection of the external abdominal oblique muscle." Anatomy figure: 35:07-01 at Human Anatomy Online, SUNY Downstate Medical Center – "Incision and reflection of the internal abdominal oblique muscle." "Anatomy photo:35:10-0100". SUNY Downstate Medical Center. Archived from the original on March 5, 2016. – "Anterior Abdominal Wall: The Rectus Abdominis Muscle" Cross section image: pembody/body12a—Plastination Laboratory at the Medical University of Vienna "Anatomy diagram: 25466.180-1". Roche Lexicon - illustrated navigator. Elsevier. Archived from the original on 2012-09-03.
== History == The ability of a soapy solution to act as a detergent has been recognized for centuries. However, it was only at the beginning of the twentieth century that the constitution of such solutions was scientifically studied. Pioneering work in this area was carried out by James William McBain at the University of Bristol. As early as 1913, he postulated the existence of "colloidal ions" to explain the good electrolytic conductivity of sodium palmitate solutions. These highly mobile, spontaneously formed clusters came to be called micelles, a term borrowed from biology and popularized by G.S. Hartley in his classic book Paraffin Chain Salts: A Study in Micelle Formation. The term micelle was coined in nineteenth century scientific literature as the ‑elle diminutive of the Latin word mica (particle), conveying a new word for "tiny particle".
Sources: en.wikipedia.org
The dry powder is normally kept at -20 °C, protected from light and moisture. Reconstituted solutions are often divided into aliquots and stored at -80 °C to reduce freeze-thaw damage.
Reverse-phase HPLC assesses purity, and mass spectrometry confirms molecular mass. The combination helps distinguish the target peptide from truncated or modified impurities.
Buffer composition, pH, adsorption to containers, and freeze-thaw history can all affect the amount of intact peptide in solution. These factors may change results even when the starting material is chemically correct.
Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.